Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...
Irish Star on MSN33m
Black Sabbath to reunite for epic final show at Villa Park with Metallica and Slayer
The original line up of Black Sabbath - Ozzy Osbourne, Geezer Butler, Tony Iommi, and Bill Ward - will play their first and ...
Annovis Bio begins pivotal phase 3 Alzheimer's drug trial
MALVERN, Pa. - Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company trading near its 52-week low of $2.99, has announced the initiation of a Phase 3 trial for its Alzheimer's disease ...